112 related articles for article (PubMed ID: 1463974)
1. Biomarker assessments in asbestos-exposed workers as indicators for selective prevention of mesothelioma or bronchogenic carcinoma: rationale and practical implementations.
Pluygers E; Baldewyns P; Minette P; Beauduin M; Gourdin P; Robinet P
Eur J Cancer Prev; 1992 Feb; 1(2):129-38. PubMed ID: 1463974
[TBL] [Abstract][Full Text] [Related]
2. Biomarker assessments in asbestos-exposed workers as indicators for selective prevention of mesothelioma or bronchogenic carcinoma: rationale and practical implementations.
Pluygers E; Baldewyns P; Minette P; Beauduin M; Gourdin P; Robinet P
Eur J Cancer Prev; 1991 Oct; 1(1):57-68. PubMed ID: 1842686
[TBL] [Abstract][Full Text] [Related]
3. [Exposure to asbestos and levels of selected tumor biomarkers].
Krajewska B; Lutz W; Piłacik B
Med Pr; 1996; 47(2):89-96. PubMed ID: 8657007
[TBL] [Abstract][Full Text] [Related]
4. Determination of tissue polypeptide antigens (TPA) and carcinoembryonic antigen (CEA) in serum: its value in the preliminary cancer risk assessment in asbestos exposed workers.
Lutz W; Krajewska B; Piłacik B
Int J Occup Med Environ Health; 1997; 10(3):259-65. PubMed ID: 9524403
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma.
Huang MS; Jong SB; Tsai MS; Lin MS; Chong IW; Lin HC; Hwang JJ
Respir Med; 1997 Mar; 91(3):135-42. PubMed ID: 9135852
[TBL] [Abstract][Full Text] [Related]
6. Assessment of biomarkers in asbestos-exposed workers as indicators of cancer risk.
Amati M; Tomasetti M; Mariotti L; Tarquini LM; Valentino M; Santarelli L
Mutat Res; 2008; 655(1-2):52-8. PubMed ID: 18638565
[TBL] [Abstract][Full Text] [Related]
7. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals.
Attanoos RL; Thomas DH; Gibbs AR
Histopathology; 2003 Oct; 43(4):387-92. PubMed ID: 14511258
[TBL] [Abstract][Full Text] [Related]
8. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with asbestos-exposed workers.
Omenn GS; Goodman GE; Thornquist MD; Rosenstock L; Barnhart S; Gylys-Colwell I; Metch B; Lund B
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):381-7. PubMed ID: 8348062
[TBL] [Abstract][Full Text] [Related]
9. Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer.
Lee YC; Yang PC; Kuo SH; Luh KT
J Formos Med Assoc; 1991 Jul; 90(7):631-6. PubMed ID: 1681012
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of C-C chemokine RANTES in asbestos exposed workers and in malignant mesothelioma patients from an hyperendemic area.
Comar M; Zanotta N; Bonotti A; Tognon M; Negro C; Cristaudo A; Bovenzi M
PLoS One; 2014; 9(8):e104848. PubMed ID: 25162674
[TBL] [Abstract][Full Text] [Related]
11. Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study.
Hollevoet K; Van Cleemput J; Thimpont J; De Vuyst P; Bosquée L; Nackaerts K; Germonpré P; Vansteelandt S; Kishi Y; Delanghe JR; van Meerbeeck JP
J Thorac Oncol; 2011 May; 6(5):889-95. PubMed ID: 21358346
[TBL] [Abstract][Full Text] [Related]
12. Carotene and retinol efficacy trial: lung cancer chemoprevention trial in heavy cigarette smokers and asbestos-exposed workers. CARET Coinvestigators and Staff.
Goodman GE; Omenn GS
Adv Exp Med Biol; 1992; 320():137-40. PubMed ID: 1442278
[No Abstract] [Full Text] [Related]
13. An intervention trial in high-risk asbestos-exposed persons.
McLarty JW
Adv Exp Med Biol; 1992; 320():141-9. PubMed ID: 1442279
[No Abstract] [Full Text] [Related]
14. Environmental exposure to asbestos in asbestos cement workers: a case of additional exposure from indiscriminate use of industrial wastes.
Szeszenia-Dabrowska N; Wilczyńska U; Szymczak W; Laskowicz K
Int J Occup Med Environ Health; 1998; 11(2):171-7. PubMed ID: 9753896
[TBL] [Abstract][Full Text] [Related]
15. [Asbestos exposure circumstances and malignant mesothelioma casuistry of the Tuscan Registry: preliminary indications on the efficacy of dust control measures introduced during the Seventies].
Silvestri S; Benvenuti A
Epidemiol Prev; 2007; 31(4 Suppl 1):75-80. PubMed ID: 18050862
[No Abstract] [Full Text] [Related]
16. Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos.
Gube M; Taeger D; Weber DG; Pesch B; Brand P; Johnen G; Müller-Lux A; Gross IM; Wiethege T; Weber A; Raithel HJ; Kraus T; Brüning T
Arch Toxicol; 2011 Mar; 85(3):185-92. PubMed ID: 20737138
[TBL] [Abstract][Full Text] [Related]
17. Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
[TBL] [Abstract][Full Text] [Related]
18. CARET, the beta-carotene and retinol efficacy trial to prevent lung cancer in asbestos-exposed workers and in smokers.
Omenn GS; Goodman G; Grizzle J; Thornquist M; Rosenstock L; Barnhart S; Anderson G; Balmes J; Cherniack M; Cone J
Anticancer Drugs; 1991 Feb; 2(1):79-86. PubMed ID: 1958856
[TBL] [Abstract][Full Text] [Related]
19. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.
Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A
Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers.
Omenn GS; Goodman G; Thornquist M; Barnhart S; Balmes J; Cherniack M; Cullen M; Glass A; Keogh J; Liu D; Meyskens F; Perloff M; Valanis B; Williams J
IARC Sci Publ; 1996; (136):67-85. PubMed ID: 8791118
[No Abstract] [Full Text] [Related]
[Next] [New Search]
